| MolName | (E)-4-[benzyl-[1-(3-chlorophenyl)-2,5-dioxopyrrolidin-3-yl]amino]-4-oxobut-2-enoic acid |
| MolecularFormula | C21H17N2O5Cl |
| Smiles | OC(/C=C/C(N(Cc1ccccc1)C(CC(N1c2cccc(Cl)c2)=O)C1=O)=O)=O |
| InChI | InChI=1S/C21H17ClN2O5/c22-15-7-4-8-16(11-15)24-19(26)12-17(21(24)29)23(18(25)9-10-20(27)28)13-14-5-2-1-3-6-14/h1-11,17H,12-13H2,(H,27,28)/t17-/m1/s1 |
| InChIK | GHYJBKOJTMXARY-QGZVFWFLSA-N |
| TotalMolweight | 412.828 |
| Molweight | 412.828 |
| MonoisotopicMass | 412.0826 |
| CLogP | 1.8474 |
| CLogS | -3.661 |
| H Acceptors | 7 |
| H Donors | 1 |
| TotalSurfaceArea | 299.41 |
| Relative PSA | 0.24168 |
| PolarSurfaceArea | 94.99 |
| Druglikeness | 4.6997 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | high |
| Nasty Functions | |
| Shape Index | 0.44828 |
| Fragments | 1 |
| Non HAtoms | 29 |
| NonCHAtoms | 8 |
| Electronegative Atoms | 8 |
| StereoCenters | 1 |
| Rotatable Bond | 6 |
| Rings Closures | 3 |
| Small Rings | 3 |
| Aromatic Rings | 2 |
| Aromatic Atoms | 12 |
| Sp3Atoms | 4 |
| Symmetricatoms | 2 |
| Amides | 2 |
| AcidicOxygens | 1 |
| StereoCon | racemate |
Click to Load Molecule:
1 - (E)-4-[benzyl-[1-(3-chlorophenyl)-2,5-dioxopyrrolidin-3-yl]amino]-4-oxobut-2-enoic acid | 2 - (E)-4-[benzyl-[1-(3-chlorophenyl)-2,5-dioxopyrrolidin-3-yl]amino]-4-oxobut-2-enoic acid